Showing 1 - 10 of 124
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act...
Persistent link: https://www.econbiz.de/10003936940
Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) in 1984. In the year Hatch-Waxman was enacted, generic utilization rates were 19 percent; in contrast, today, the generic utilization rate is...
Persistent link: https://www.econbiz.de/10012462928
Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act (Hatch-Waxman) in 1984. In the year Hatch-Waxman was enacted, generic utilization rates were 19 percent; in contrast, today, the generic utilization rate is...
Persistent link: https://www.econbiz.de/10008624569
This article discusses the evolving field of pharmacogenomics, which is the science of using genomic markers to predict drug response, and how it may impact the future costs, risks and returns to pharmaceutical research and development (R&D). We uncover a number of factors and issues that are...
Persistent link: https://www.econbiz.de/10004993640
Persistent link: https://www.econbiz.de/10009298454
Persistent link: https://www.econbiz.de/10009265015
Increased spending on pharmaceuticals continues to foster debate over healthcare policy. The increasing costs of bringing products to the market, as well as increased utilization of pharmaceuticals contribute to increased pharmaceutical expenditure; however, appropriate pharmaceutical use can, in...
Persistent link: https://www.econbiz.de/10005449267
Persistent link: https://www.econbiz.de/10003516451
White seniors report better health than Black seniors in urban areas in Sao Paulo, Brazil. This is the case even after controlling for baseline health conditions and several demographic, socio-economic and family support characteristics. Furthermore, adjusted racial disparities in self-reported...
Persistent link: https://www.econbiz.de/10013223999
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10013311658